Skip to main content

PDGFB in breast cancer initiation, progression, and metastasis

PDGFB in Breast Cancer Initiation,Progression, and Metastasis - A cross journal collection

Submission deadline: 31 March 2022

The family of platelet derived growth factors (PDGF) encompasses proangiogenic factors, which have been associated with progression of malignancies, including breast cancer. Recent studies indicated that expression of PDGFB is an important prognostic factor in certain breast cancer types, and that combination of PDGFR inhibitors with targeted therapy could significantly increase survival. In this cross-journal collection, we welcome a wide range of articles on the role of PDGFB in mammary gland development, breast cancer initiation, progression, and metastasis, including primary research articles, reviews, and perspectives. 

To express your interest to contribute, please contact the Editor-in-Chief of the respective journal:

Breast Cancer Research: Lewis A. Chodosh (
Journal of Mammary Gland Biology and Neoplasia: Zuzana Koledova (
Breast Cancer Research & Treatment: William J. Gradishar (

Participating journals:
Breast Cancer Research: Submit here

Breast Cancer Research and Treatment: Submit here

Journal of Mammary Gland Biology and Neoplasia: Submit here

There are currently no articles in this collection.